Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (271-280 of 491) with videos related to

Pageof 50
Sort By:
Hepatology (Baltimore, Md.)|November 16, 2017
Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resectionPatrick Starlinger, David Pereyra, Stefanie Haegele, et al.
JHEP Reports : Innovation in Hepatology|December 21, 2023
Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortalityLukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.
Gastrointestinal Endoscopy|June 2, 2026
Corrigendum to "Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades." Gastrointest Endosc 2025;102:733-7Nikolaus Pfisterer, Florian Riedl, Michael Schwarz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 5, 2020
Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ populationCaroline Schmidbauer, David Chromy, Victor Schmidbauer, et al.
Journal of Viral Hepatitis|September 5, 2022
HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemicLukas Hartl, Mathias Jachs, David Bauer, et al.
Gastrointestinal Endoscopy|May 5, 2025
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decadesNikolaus Pfisterer, Florian Riedl, Michael Schwarz, et al.
Journal of Clinical Medicine|November 28, 2018
De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial InfarctionMatthias Steininger, Max-Paul Winter, Thomas Reiberger, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Wiener Klinische Wochenschrift|June 20, 2018
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic functionBernhard Scheiner, Paul René Stammet, Sebastian Pokorny, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 7, 2026
Radiomics-Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine CT ScansCeline Sin, Martin Luther Watzenboeck, Eugenia Iofinova, et al.
Pageof 50

Showing results (271-280 of 491) with videos related to

Sort By:
Pageof 50
Hepatology (Baltimore, Md.)|November 16, 2017
Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resectionPatrick Starlinger, David Pereyra, Stefanie Haegele, et al.
JHEP Reports : Innovation in Hepatology|December 21, 2023
Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortalityLukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.
Gastrointestinal Endoscopy|June 2, 2026
Corrigendum to "Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decades." Gastrointest Endosc 2025;102:733-7Nikolaus Pfisterer, Florian Riedl, Michael Schwarz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 5, 2020
Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ populationCaroline Schmidbauer, David Chromy, Victor Schmidbauer, et al.
Journal of Viral Hepatitis|September 5, 2022
HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemicLukas Hartl, Mathias Jachs, David Bauer, et al.
Gastrointestinal Endoscopy|May 5, 2025
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decadesNikolaus Pfisterer, Florian Riedl, Michael Schwarz, et al.
Journal of Clinical Medicine|November 28, 2018
De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial InfarctionMatthias Steininger, Max-Paul Winter, Thomas Reiberger, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Wiener Klinische Wochenschrift|June 20, 2018
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic functionBernhard Scheiner, Paul René Stammet, Sebastian Pokorny, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 7, 2026
Radiomics-Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine CT ScansCeline Sin, Martin Luther Watzenboeck, Eugenia Iofinova, et al.
Pageof 50